Namrata Choudhari

Namrata Choudhari has a diverse work experience in the field of biomedical research. Namrata started their career at Rutgers University–Camden, where they worked as a Teaching Assistant from September 2006 to May 2007. Namrata then continued their research work at Rutgers University–Camden as a Research Assistant from September 2007 to May 2008, focusing on studying the variation of thyroid hormone levels in the cerebrospinal fluid of adult rats through live animal surgeries.

In 2009, Namrata joined The Children's Hospital of Philadelphia as a Research Assistant, where they contributed to the preclinical evaluation and targeted therapeutic approaches for fusion BRAF mutations found in pediatric low-grade gliomas. Namrata generated cell model systems of pediatric low-grade gliomas using DNA plasmid engineering and retroviral-mediated infection approaches. Namrata worked in this role until May 2011.

In 2013, they became a Research Assistant at The Centre for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia, focusing on investigating and developing RNA-based therapeutics for pediatric brain tumors. Namrata'swork significantly improved the tolerability and side effect profile of T-cell-based immunotherapies for children diagnosed with pediatric cancers. Namrata also worked on gene profiling for FFPE samples and DIPG exosome and cells using miRNA and cancer pathway panels.

In 2021, Namrata joined Kite Pharma as a Senior Research Scientist in Cell Biology. Namrata'sspecific responsibilities and accomplishments in this role are not mentioned.

Currently, they are also working at Tmunity Therapeutics Incorporated, where they initially started as a Scientist in March 2021 and later transitioned into the role of Senior Scientist in T cell engineering and gene editing in October 2022. It is not mentioned when their tenure at Tmunity Therapeutics will end.

Overall, Namrata Choudhari has accumulated extensive experience in the field of biomedical research, particularly in the areas of cell biology, T cell engineering, gene editing, and targeted therapeutics for pediatric cancers.

Namrata Choudhari pursued a Master of Science (MS) degree in Biology from Rutgers University - Camden from 2006 to 2009. Prior to that, they completed a Master of Science (MS) degree in Biochemistry at the University of Lucknow from 2002 to 2004. In addition, they acquired a certification in "Group 1: Biomedical Researchers" from the CITI Program in September 2022.